Want to invest in artificial intelligence (AI), cloud computing, digital media, and e-commerce in one fell swoop? You could ...

Vertex Pharmaceuticals Incorporated remains a top Buy with a strong cystic fibrosis franchise, innovative pipeline, and cell therapies. Click for my VRTX update.

Vertex Pharmaceuticals (NasdaqGS:VRTX) recently received approval from the European Commission for ALYFTREK, enhancing its reach in European markets with new reimbursement agreements in Ireland and ...

The hefty 40% price cut works out at $180 off the regular price and brings it down to its lowest price since Black Friday.

This is the fourth installment in a multi-part series on evaluating various RAG systems using Tonic Validate, a RAG evaluation and benchmarking platform. In this installment, we pit OpenAI's RAG Assis ...

Vertex Pharmaceuticals encountered a challenging first quarter in 2025, as both revenue and non-GAAP profit fell short of ...

According to Benzinga Pro, Vertex Pharmaceuticals's peer group average for short interest as a percentage of float is 6.62%, which means the company has less short interest than most of its peers. Did ...

The Boston Arts Academy Foundation received a $1 million gift from Joshua Boger, the founder and former CEO of Vertex Pharmaceuticals, and his wife, Amy.

PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded ...

Gemini CLI is your go-to terminal tool for debugging code, managing files, or writing scripts directly from your terminal.

Janus Henderson Investors, an investment management company, released its “Janus Henderson Venture Fund” first quarter 2025 ...

Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug ...